Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oventus

Oventus
2012 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
OVN STOCK SYMBOL
$0.51 SHARE PRICE (As of Tuesday Closing)
Description

Oventus Medical Ltd is a medical device company. It is engaged in developing oral appliance for the treatment of sleep apnoea and snoring. Its products include O2Vent Mono and O2Vent.

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
ASX
Primary Office
  • PO Box 190
  • Indooroopilly, Queensland 4068
  • Australia

+61 (07) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oventus’s full profile, request a free trial.

Oventus Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.14 - $0.62 $54.5M $0.48 496K 107M

Oventus Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 17,064 17,064 25,292 16,177
Revenue 210 338
EBITDA (4,109) (4,509)
Net Income (4,547) (4,906)
Total Assets 11,616 10,850
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oventus Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Oventus‘s full profile, request access.

Request full access to PitchBook

Oventus Executive Team (2)

Name Title Board
Seat
Contact
Info
Neil Anderson Chief Executive Officer & Managing Director
Chris Hart Founder and Clinical Director

Oventus Board Members (1)

Name Representing Role Since Contact
Info
Mel Bridges Oventus Chairman 000 0000